Megan Crone1,2, Jean K Mah3. 1. Division of Neurology, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. hollanmt@ucalgary.ca. 2. Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, Alberta, T3B 6A8, Canada. hollanmt@ucalgary.ca. 3. Division of Neurology, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to summarize the current and emerging therapies for Duchenne muscular dystrophy (DMD). RECENT FINDINGS: Coinciding with new standardized care guidelines, there are a growing number of therapeutic options to treat males with DMD. Treatment of the underlying pathobiology, such as micro-dystrophin gene replacement, exon skipping, stop codon read-through agents, and utrophin modulators showed variable success in animal and human studies. Symptomatic therapies to target muscle ischemia, enhance muscle regeneration, prevent muscle fibrosis, inhibit myostatin, and reduce inflammation are also under investigation. DMD is a complex, heterogeneous degenerative disease. The pharmacological and technological achievements made in recent years, plus timely supportive interventions will likely lead to an improved quality of life for many individuals with DMD.
PURPOSE OF REVIEW: The purpose of this review is to summarize the current and emerging therapies for Duchenne muscular dystrophy (DMD). RECENT FINDINGS: Coinciding with new standardized care guidelines, there are a growing number of therapeutic options to treat males with DMD. Treatment of the underlying pathobiology, such as micro-dystrophin gene replacement, exon skipping, stop codon read-through agents, and utrophin modulators showed variable success in animal and human studies. Symptomatic therapies to target muscle ischemia, enhance muscle regeneration, prevent muscle fibrosis, inhibit myostatin, and reduce inflammation are also under investigation. DMD is a complex, heterogeneous degenerative disease. The pharmacological and technological achievements made in recent years, plus timely supportive interventions will likely lead to an improved quality of life for many individuals with DMD.
Authors: David J Birnkrant; Katharine M D Bushby; Raouf S Amin; John R Bach; Joshua O Benditt; Michelle Eagle; Jonathan D Finder; Maninder S Kalra; John T Kissel; Anastassios C Koumbourlis; Richard M Kravitz Journal: Pediatr Pulmonol Date: 2010-08
Authors: Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin Journal: Lancet Neurol Date: 2009-11-27 Impact factor: 44.182
Authors: M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel Journal: Am J Hum Genet Date: 1989-10 Impact factor: 11.025
Authors: Giulio Cossu; Stefano C Previtali; Sara Napolitano; Maria Pia Cicalese; Francesco Saverio Tedesco; Francesca Nicastro; Maddalena Noviello; Urmas Roostalu; Maria Grazia Natali Sora; Marina Scarlato; Maurizio De Pellegrin; Claudia Godi; Serena Giuliani; Francesca Ciotti; Rossana Tonlorenzi; Isabella Lorenzetti; Cristina Rivellini; Sara Benedetti; Roberto Gatti; Sarah Marktel; Benedetta Mazzi; Andrea Tettamanti; Martina Ragazzi; Maria Adele Imro; Giuseppina Marano; Alessandro Ambrosi; Rossana Fiori; Maria Pia Sormani; Chiara Bonini; Massimo Venturini; Letterio S Politi; Yvan Torrente; Fabio Ciceri Journal: EMBO Mol Med Date: 2015-12 Impact factor: 12.137
Authors: Angela Lek; Yuanfan Zhang; Keryn G Woodman; Shushu Huang; Alec M DeSimone; Justin Cohen; Vincent Ho; James Conner; Lillian Mead; Andrew Kodani; Anna Pakula; Neville Sanjana; Oliver D King; Peter L Jones; Kathryn R Wagner; Monkol Lek; Louis M Kunkel Journal: Sci Transl Med Date: 2020-03-25 Impact factor: 17.956
Authors: Virginie Mournetas; Emmanuelle Massouridès; Jean-Baptiste Dupont; Etienne Kornobis; Hélène Polvèche; Margot Jarrige; Alan R L Dorval; Maxime R F Gosselin; Antigoni Manousopoulou; Spiros D Garbis; Dariusz C Górecki; Christian Pinset Journal: J Cachexia Sarcopenia Muscle Date: 2021-02-14 Impact factor: 12.910
Authors: Leonela Amoasii; Hui Li; Yu Zhang; Yi-Li Min; Efrain Sanchez-Ortiz; John M Shelton; Chengzu Long; Alex A Mireault; Samadrita Bhattacharyya; John R McAnally; Rhonda Bassel-Duby; Eric N Olson Journal: Nat Commun Date: 2019-10-04 Impact factor: 14.919